Beacon Behavioral Partners Welcomes Novus Neurology and SunCoast Psychiatry
Partnerships Expand Access to Advanced Neurological and Psychiatric Care in Florida and AlabamaBATON ROUGE, La., March 24, 2026 (GLOBE NEWSWIRE)...
Partnerships Expand Access to Advanced Neurological and Psychiatric Care in Florida and AlabamaBATON ROUGE, La., March 24, 2026 (GLOBE NEWSWIRE)...
VANCOUVER, BC / ACCESS Newswire / March 24, 2026 / BioNxt Solutions Inc. ("BioNxt" or the "Company") (CSE:BNXT)(OTCQB:BNXTF)(FSE:BXT), a bioscience...
FDA clearance quickly follows Photonova Spectra’s debut at the Radiological Society of North America (RSNA) 2025 Annual Meeting, marking rapid...
FARMINGTON, Conn.--(BUSINESS WIRE)--Horizon Technology Finance Corporation (NASDAQ: HRZN) (“Horizon”) (the “Company”), an affiliate of Monroe Capital, today announced it has...
National Data Reveals Wide Variation in the Adherence to Basic Cognitive Assessment in Dementia CareSAN FRANCISCO, March 19, 2026 /PRNewswire/ --...
The AI-powered Epidemiology Database is a comprehensive repository covering 500+ disease indications with 10-year epidemiology forecasts across the seven major...
Completion of Texas Medical Center Innovation program connects Kneu with the world'slargest medical complex as deployments advance across nation's leading...
Newly formed executive team initiates global search for differentiated therapeutic assets for neurology and oncology indications, two of biopharma's largest...
Combination of high quality, variable-rich, curated EHR data with ophthalmic images will expedite disease detection, monitoring, and aid in preventionSAN...
Combination of high quality, variable-rich, curated EHR data with ophthalmic images will expedite disease detection, monitoring, and aid in preventionSAN...
Combination of high quality, variable-rich, curated EHR data with ophthalmic images will expedite disease detection, monitoring, and aid in preventionSAN...
Post hoc analyses of two Phase 2 trials examine the potential benefits of solengepras, a once-daily, oral, non-dopaminergic GPR6 inhibitor,...
RAP-219’s lead program demonstrated robust and consistent activity in patients with focal onset seizures (FOS) in Phase 2a trial; initiation...
A collaboration with Dimension NXG leverages the efficiency of Ambient Scientific's GPX-10 processor to bring offline, privacy-focused safety and health monitoring...
The six-month integration embedded Kneu's smartphone-based app into Cedars-Sinai's Parkinson's program, capturing more than 46,000 motor, speech, and cognitive measures...
SUMMIT RISE is expected to enroll up to 500 patients to evaluate the performance of Route 92 Medical’s neurovascular intervention...
Dr. Robert Lenz brings over 20 years of experience in neuroscience drug developmentNEW YORK, March 09, 2026 (GLOBE NEWSWIRE) --...
LEXINGTON, Mass., March 09, 2026 (GLOBE NEWSWIRE) -- Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage biopharmaceutical...
WARREN, N.J., March 09, 2026 (GLOBE NEWSWIRE) -- Tevogen (“Tevogen Bio Holdings Inc.” or “Company”) (Nasdaq: TVGN) today announced the...
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), today announced the publication of data from...